RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology

J Clin Exp Hematop. 2023 Dec 26;63(4):240-245. doi: 10.3960/jslrt.23028. Epub 2023 Oct 28.

Abstract

Mature B-cell acute lymphoblastic leukemia (ALL) is defined by the expression of light chain-restricted surface immunoglobulin (sIg) and usually has features of the leukemic phase of Burkitt lymphoma including FAB-L3 morphology and MYC rearrangement. Recently, another distinct entity in childhood mature B-cell ALL has been characterized as non-L3 morphology and KMT2A rearrangement. Here we report an unusual case of mature B-cell ALL that presented with RUNX1 rearrangement. A 65-year-old male was admitted to our department for thorough examination of leukocytosis and thrombocytopenia. The patient's bone marrow was hypercellular and infiltrated with 97.8% myeloperoxidase-negative, medium-to-large-sized blasts without cytoplasmic vacuoles. Immunophenotypes were characterized by the presence of light chain-restricted sIg and the lack of immature markers, indicating a diagnosis of mature B-cell ALL with L2 morphology: sIg-κ+, CD19+, CD20+, CD22+, CD79a+, TdT-, and CD34-. G-banding combined with spectral karyotyping showed the following complex karyotype: 45,X,der(Y;10)(p10;q10),del(13)(q?),inv(21)(p13q22.1). Fluorescence in situ hybridization revealed separated signals of RUNX1 at 21q22.1, whereas rearrangements of MYC and KMT2A were not found. To our knowledge, inv(21)(p13q22.1) involving RUNX1 is a novel cytogenetic aberration and this is the first case of mature B-cell ALL that presented with RUNX1 rearrangement. Thus, RUNX1 may be implicated in the pathogenesis of mature B-cell ALL showing non-L3 morphology without MYC rearrangement.

Keywords: RUNX1 rearrangement; fluorescence in situ hybridization; mature B-cell acute lymphoblastic leukemia; non-L3 morphology.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Burkitt Lymphoma* / genetics
  • Core Binding Factor Alpha 2 Subunit / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Lymphoma, B-Cell* / diagnosis
  • Lymphoma, B-Cell* / genetics
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 protein, human